Abstract
Radiation recall dermatitis (RRD) is an acute inflammation of the skin, i.e., produced by drugs, most commonly chemotherapeutic treatments, in an area of the body that has been treated with radiation in the past. This case report describes the clinical experience of a triple-negative breast cancer patient who developed RRD after postoperative radiotherapy following adjuvant capecitabine treatment. The timing of chemotherapy after radiation therapy and the improvement in radiation dermatitis following capecitabine avoidance suggest that the reaction was a true radiation recall phenomenon.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
